Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.22

€2.22

-
-
-
-

-

 
27.03.21 / Tradegate WKN: A0H1J1 / Symbol: PDLI / Name: PDL BioPharma / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
-
06.10.20
buy
-
04.10.20
-
23.09.20
Your prediction

PDL BioPharma Inc. Stock

With 1 Buy predictions and 2 Sell predictions the community is currently undecided on PDL BioPharma Inc..
Our community identified positive and negative aspects for PDL BioPharma Inc. stock for the coming years. 1 users see the criterium "Management" as a plus for the PDL BioPharma Inc. stock. On the other hand our users think that "Market Position" could be a problem in the future.

Pros and Cons of PDL BioPharma Inc. in the next few years

Pros
1
Capable Management
1
Differentiated customer and product portfolio
1
Revenue growth >5% per year expected
Cons
1
Below average Marketposition
1
EBIT decline/stagnation expected
1
Few uniques

Performance of PDL BioPharma Inc. vs. its peers

Security Change (%) 1w 1m 1y YTD 3y 5y
PDL BioPharma Inc. - - - - - - -
Flexion Therapeutics Inc. -2.140% -14.907% -27.128% -15.432% -23.464% - -
Aravive, Inc. -0.820% -15.596% -23.967% -46.199% -14.019% - -
Corvus Pharmaceuticals Inc -2.420% -6.202% -3.200% 24.742% -19.868% -71.462% -81.195%

Comments

Prediction Buy
Perf. (%) -15.88%
Target price 5.232
Change
Ends at 08.12.17

(Laufzeit überschritten)
Show more

Prediction Buy
Perf. (%) -15.88%
Target price 5.232
Change
Ends at 08.12.17

Biopharma-Bestand

Stimme dieser Vorhersage und Menge zu. Kauf das. EPS positiv.

Show more

Other discussions about PDL BioPharma Inc. Stock

New thread Forum